Published in Cancer Weekly, September 7th, 2004
The test that counts cancer cells in bloodstreams of patients with advanced breast cancer speeds the determination of effectiveness of a therapy to weeks instead of months, according to the study led by the University of Texas M.D. Anderson Cancer Center and published in the August 19 edition of The New England Journal of Medicine.
Dr. Massimo Cristofanilli, an associate professor in M.D. Anderson's department of breast medical oncology and the study's lead author, said it confirmed that tumors circulating in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.